{"sent_idx": "139", "frame_idx": "11", "ev": "In the MoA group, anodal tDCS did not induce any significant effect on VEP amplitudes as well (Table 1).", "icos": [["1", "anodal tDCS", "MoA", "VEP amplitudes"]], "sample": "x"}
{"sent_idx": "14", "frame_idx": "2", "ev": "Preventive treatment with anodal tDCS turned out to be beneficial in MoA: migraine attack frequency, migraine days, attack duration and acute medication intake significantly decreased during the treatment period compared to pre-treatment baseline (all p < 0.05), and this benefit persisted on average 4.8 weeks after the end of tDCS.", "icos": [["0.999418", "tDCS", "tDCS", "migraine attack frequency , migraine days , attack duration and acute medication intake"], ["0.99918824", "tDCS", "anodal tDCS", "migraine attack frequency , migraine days , attack duration and acute medication intake"], ["0.99918824", "tDCS", "Anodal tDCS", "migraine attack frequency , migraine days , attack duration and acute medication intake"], ["0.99272835", "tDCS", "migraine preventive treatment", "migraine attack frequency , migraine days , attack duration and acute medication intake"], ["0.98190284", "tDCS", "Anodal tDCS stimulation", "migraine attack frequency , migraine days , attack duration and acute medication intake"]], "sample": "c"}
{"sent_idx": "30", "frame_idx": "4", "ev": "Preventive treatment with anodal tDCS turned out to be beneficial in MoA: migraine attack frequency, migraine days, attack duration and acute medication intake significantly decreased during the treatment period compared to pre-treatment baseline (all p < 0.05), and this benefit persisted on average 4.8 weeks after the end of tDCS.", "icos": [["0.999418", "tDCS", "tDCS", "migraine attack frequency , migraine days , attack duration and acute medication intake"], ["0.99918824", "tDCS", "anodal tDCS", "migraine attack frequency , migraine days , attack duration and acute medication intake"], ["0.99918824", "tDCS", "Anodal tDCS", "migraine attack frequency , migraine days , attack duration and acute medication intake"], ["0.99272835", "tDCS", "migraine preventive treatment", "migraine attack frequency , migraine days , attack duration and acute medication intake"], ["0.98190284", "tDCS", "Anodal tDCS stimulation", "migraine attack frequency , migraine days , attack duration and acute medication intake"]], "sample": "c"}
{"sent_idx": "136", "frame_idx": "8", "ev": "In the HV group, anodal tDCS stimulation had no effect on PR-VEP first block amplitude (N1P1: 6.1 \u03bcV \u00b12.0 at T0 vs. 6.8 \u03bcV \u00b12.6 at T1; p = 0.45; P1N2: 6.6 \u03bcV \u00b12.1 at T0 vs. 6.5 \u03bcV \u00b12.0 at T1; p = 0.49), and did not modify the amplitude of subsequent blocks (Table 1).", "icos": [["0.9996332", "tDCS stimulation", "tDCS stimulation", "amplitude of subsequent blocks"], ["0.9996075", "tDCS stimulation", "tDCS", "amplitude of subsequent blocks"], ["0.99959725", "tDCS stimulation", "Anodal tDCS stimulation", "amplitude of subsequent blocks"], ["0.9995764", "tDCS stimulation", "anodal tDCS", "amplitude of subsequent blocks"], ["0.9995764", "tDCS stimulation", "Anodal tDCS", "amplitude of subsequent blocks"]], "sample": "c"}
{"sent_idx": "136", "frame_idx": "9", "ev": "In the HV group, anodal tDCS stimulation had no effect on PR-VEP first block amplitude (N1P1: 6.1 \u03bcV \u00b12.0 at T0 vs. 6.8 \u03bcV \u00b12.6 at T1; p = 0.45; P1N2: 6.6 \u03bcV \u00b12.1 at T0 vs. 6.5 \u03bcV \u00b12.0 at T1; p = 0.49), and did not modify the amplitude of subsequent blocks (Table 1).", "icos": [["0.99962115", "tDCS stimulation", "tDCS stimulation", "PR - VEP first block amplitude"], ["0.999616", "tDCS stimulation", "tDCS", "PR - VEP first block amplitude"], ["0.9996013", "tDCS stimulation", "anodal tDCS", "PR - VEP first block amplitude"], ["0.9996013", "tDCS stimulation", "Anodal tDCS", "PR - VEP first block amplitude"], ["0.9995882", "tDCS stimulation", "Anodal tDCS stimulation", "PR - VEP first block amplitude"]], "sample": "c"}
{"sent_idx": "138", "frame_idx": "10", "ev": "tDCS was able to strengthen habituation in HV at T1 (p = 0.024, Figure 2 Panel A) but this change in habituation did not persist after 3 hours (T2) where it returned on average to baseline values.", "icos": [["0.99928266", "tDCS", "tDCS", "habituation"], ["0.98864627", "tDCS", "migraine preventive treatment", "habituation"], ["0.97152776", "tDCS", "tDCS stimulation", "habituation"], ["0.89431274", "tDCS", "excitatory tDCS", "habituation"], ["0.86800134", "tDCS", "anodal tDCS", "habituation"]], "sample": "c"}
{"sent_idx": "143", "frame_idx": "15", "ev": "Hence, during the 8 weeks of anodal tDCS treatment, there was already on average a significant reduction of migraine frequency, which was decreased from 9.6 days in 2 months to 6.3 (34%,p = 0.005), while there was a remarkable reduction in the number of migraine days from 15 to 8 (47%, p = 0.01).", "icos": [["0.9996216", "tDCS", "tDCS", "migraine frequency"], ["0.99950874", "tDCS", "anodal tDCS", "migraine frequency"], ["0.99950874", "tDCS", "Anodal tDCS", "migraine frequency"], ["0.99943393", "tDCS", "excitatory tDCS", "migraine frequency"], ["0.9991763", "tDCS", "tDCS stimulation", "migraine frequency"]], "sample": "c"}
{"sent_idx": "143", "frame_idx": "16", "ev": "Hence, during the 8 weeks of anodal tDCS treatment, there was already on average a significant reduction of migraine frequency, which was decreased from 9.6 days in 2 months to 6.3 (34%,p = 0.005), while there was a remarkable reduction in the number of migraine days from 15 to 8 (47%, p = 0.01).", "icos": [["0.9996344", "tDCS", "tDCS", "number of migraine days"], ["0.9995378", "tDCS", "anodal tDCS", "number of migraine days"], ["0.9995378", "tDCS", "Anodal tDCS", "number of migraine days"], ["0.9994266", "tDCS", "excitatory tDCS", "number of migraine days"], ["0.999421", "tDCS", "tDCS stimulation", "number of migraine days"]], "sample": "c"}
{"sent_idx": "150", "frame_idx": "24", "ev": "The evolution under tDCS treatment was similar in both groups: patients without drug therapy had a frequency reduction from 9.2 \u00b11.64 to 5.4 \u00b1 2.19 attacks in two months (p = 0.04), while in patients under preventive therapy the frequency decreased from 10 \u00b1 1.4 to 7.2 \u00b1 1.8 attacks in two months (p = 0.04).", "icos": [["0.99963725", "tDCS", "tDCS", "frequency reduction"], ["0.99929416", "tDCS", "migraine preventive treatment", "frequency reduction"], ["0.99924684", "tDCS", "anodal tDCS", "frequency reduction"], ["0.99924684", "tDCS", "Anodal tDCS", "frequency reduction"], ["0.9991806", "tDCS", "excitatory tDCS", "frequency reduction"]], "sample": "c"}
